Bridges Investment Management Inc buys $1,024,531 stake in Monsanto Company (MON)

Monsanto Company (MON) : Bridges Investment Management Inc scooped up 1,000 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 10,890 shares of Monsanto Company which is valued at $1,024,531.Monsanto Company makes up approximately 0.18% of Bridges Investment Management Inc’s portfolio.

Monsanto Company opened for trading at $93.78 and hit $94.95 on the upside on Wednesday, eventually ending the session at $94, with a gain of 0.11% or 0.1 points. The heightened volatility saw the trading volume jump to 25,18,072 shares. Company has a market cap of $41,063 M.

Other Hedge Funds, Including , Seaward Management Limited Partnership reduced its stake in MON by selling 3,424 shares or 7.31% in the most recent quarter. The Hedge Fund company now holds 43,427 shares of MON which is valued at $4,085,612. Monsanto Company makes up approx 0.22% of Seaward Management Limited Partnership’s portfolio.High Point Bank Trust Co reduced its stake in MON by selling 427 shares or 30.76% in the most recent quarter. The Hedge Fund company now holds 961 shares of MON which is valued at $90,411. Monsanto Company makes up approx 0.02% of High Point Bank Trust Co’s portfolio. Alpha Windward sold out all of its stake in MON during the most recent quarter. The investment firm sold 1,359 shares of MON which is valued $120,095.Fjarde Ap-fonden Fourth Swedish National Pension Fund boosted its stake in MON in the latest quarter, The investment management firm added 4,621 additional shares and now holds a total of 101,273 shares of Monsanto Company which is valued at $8,949,495. Monsanto Company makes up approx 0.21% of Fjarde Ap-fonden Fourth Swedish National Pension Fund’s portfolio. Eqis Capital Management added MON to its portfolio by purchasing 2,688 company shares during the most recent quarter which is valued at $233,238. Monsanto Company makes up approx 0.02% of Eqis Capital Management’s portfolio.

On the company’s financial health, Monsanto Company reported $2.42 EPS for the quarter, based on the information available during the earnings call on Apr 6, 2016. Analyst had a consensus estimate of $2.42. The company had revenue of $4532.00 million for the quarter, compared to analysts expectations of $4734.36 million. The company’s revenue was down -12.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.90 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .Monsanto Company was Downgraded by Citigroup to ” Neutral” on Mar 14, 2016. Monsanto Company was Downgraded by Goldman to ” Sell” on Mar 4, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.